An Evaluation of Supplementary Prescribing in Nursing and Pharmacy

Final Report for the Department of Health

Paul Bissell, Richard Cooper, L Preston, Claire Anderson, Anthony Avery, V James, A Hutchinson, Joanne Lymn, E Murphy, J Ratcliffe

Research output: Book/ReportCommissioned report

Abstract

Supplementary prescribing was introduced in 2003 for nurses and pharmacists (and more recently for other health professionals). It allows suitably trained professionals to prescribe for patients in accordance with a Clinical Management Plan (CMP) following initial diagnosis by an independent medical prescriber and with the patient’s agreement.
Aims
This research aimed to explore how supplementary prescribing in nursing and pharmacy was working in practice in England. The objectives of the project were to evaluate barriers and facilitators to the implementation of supplementary prescribing, patient and professional experiences, prescribing practices and issues around the safety and costs of supplementary prescribing.
Method
The research consisted of 3 stages: in stage 1, a thematic review of published and ‘grey’ literatures, and interviews with key stakeholders involved in supplementary prescribing were undertaken; stage 2 comprised an analysis of community and primary care nurse and pharmacist prescribing using PACT
data (2004 – 2007) and a postal questionnaire survey of nurse (n=518) and pharmacist (n=411) supplementary prescribers; in stage 3, ten detailed case studies of supplementary prescribing practice in various settings were conducted, utilising observations, interviews and prescribing data. Research
was undertaken from 2006 to 2008.
Original languageEnglish
Commissioning bodyDepartment of Health, Social Services and Public Safety
Number of pages102
Publication statusPublished - 2008
Externally publishedYes

Fingerprint

Pharmacists
Nursing
Nurses
Health
Interviews
Literature
Research
England
Primary Health Care
Safety
Costs and Cost Analysis

Cite this

Bissell, P., Cooper, R., Preston, L., Anderson, C., Avery, A., James, V., ... Ratcliffe, J. (2008). An Evaluation of Supplementary Prescribing in Nursing and Pharmacy: Final Report for the Department of Health.
Bissell, Paul ; Cooper, Richard ; Preston, L ; Anderson, Claire ; Avery, Anthony ; James, V ; Hutchinson, A ; Lymn, Joanne ; Murphy, E ; Ratcliffe, J. / An Evaluation of Supplementary Prescribing in Nursing and Pharmacy : Final Report for the Department of Health. 2008. 102 p.
@book{219f105666dc45f697699b62e92d34f3,
title = "An Evaluation of Supplementary Prescribing in Nursing and Pharmacy: Final Report for the Department of Health",
abstract = "Supplementary prescribing was introduced in 2003 for nurses and pharmacists (and more recently for other health professionals). It allows suitably trained professionals to prescribe for patients in accordance with a Clinical Management Plan (CMP) following initial diagnosis by an independent medical prescriber and with the patient’s agreement.AimsThis research aimed to explore how supplementary prescribing in nursing and pharmacy was working in practice in England. The objectives of the project were to evaluate barriers and facilitators to the implementation of supplementary prescribing, patient and professional experiences, prescribing practices and issues around the safety and costs of supplementary prescribing.MethodThe research consisted of 3 stages: in stage 1, a thematic review of published and ‘grey’ literatures, and interviews with key stakeholders involved in supplementary prescribing were undertaken; stage 2 comprised an analysis of community and primary care nurse and pharmacist prescribing using PACTdata (2004 – 2007) and a postal questionnaire survey of nurse (n=518) and pharmacist (n=411) supplementary prescribers; in stage 3, ten detailed case studies of supplementary prescribing practice in various settings were conducted, utilising observations, interviews and prescribing data. Researchwas undertaken from 2006 to 2008.",
author = "Paul Bissell and Richard Cooper and L Preston and Claire Anderson and Anthony Avery and V James and A Hutchinson and Joanne Lymn and E Murphy and J Ratcliffe",
year = "2008",
language = "English",

}

Bissell, P, Cooper, R, Preston, L, Anderson, C, Avery, A, James, V, Hutchinson, A, Lymn, J, Murphy, E & Ratcliffe, J 2008, An Evaluation of Supplementary Prescribing in Nursing and Pharmacy: Final Report for the Department of Health.

An Evaluation of Supplementary Prescribing in Nursing and Pharmacy : Final Report for the Department of Health. / Bissell, Paul; Cooper, Richard; Preston, L; Anderson, Claire; Avery, Anthony; James, V; Hutchinson, A; Lymn, Joanne; Murphy, E; Ratcliffe, J.

2008. 102 p.

Research output: Book/ReportCommissioned report

TY - BOOK

T1 - An Evaluation of Supplementary Prescribing in Nursing and Pharmacy

T2 - Final Report for the Department of Health

AU - Bissell, Paul

AU - Cooper, Richard

AU - Preston, L

AU - Anderson, Claire

AU - Avery, Anthony

AU - James, V

AU - Hutchinson, A

AU - Lymn, Joanne

AU - Murphy, E

AU - Ratcliffe, J

PY - 2008

Y1 - 2008

N2 - Supplementary prescribing was introduced in 2003 for nurses and pharmacists (and more recently for other health professionals). It allows suitably trained professionals to prescribe for patients in accordance with a Clinical Management Plan (CMP) following initial diagnosis by an independent medical prescriber and with the patient’s agreement.AimsThis research aimed to explore how supplementary prescribing in nursing and pharmacy was working in practice in England. The objectives of the project were to evaluate barriers and facilitators to the implementation of supplementary prescribing, patient and professional experiences, prescribing practices and issues around the safety and costs of supplementary prescribing.MethodThe research consisted of 3 stages: in stage 1, a thematic review of published and ‘grey’ literatures, and interviews with key stakeholders involved in supplementary prescribing were undertaken; stage 2 comprised an analysis of community and primary care nurse and pharmacist prescribing using PACTdata (2004 – 2007) and a postal questionnaire survey of nurse (n=518) and pharmacist (n=411) supplementary prescribers; in stage 3, ten detailed case studies of supplementary prescribing practice in various settings were conducted, utilising observations, interviews and prescribing data. Researchwas undertaken from 2006 to 2008.

AB - Supplementary prescribing was introduced in 2003 for nurses and pharmacists (and more recently for other health professionals). It allows suitably trained professionals to prescribe for patients in accordance with a Clinical Management Plan (CMP) following initial diagnosis by an independent medical prescriber and with the patient’s agreement.AimsThis research aimed to explore how supplementary prescribing in nursing and pharmacy was working in practice in England. The objectives of the project were to evaluate barriers and facilitators to the implementation of supplementary prescribing, patient and professional experiences, prescribing practices and issues around the safety and costs of supplementary prescribing.MethodThe research consisted of 3 stages: in stage 1, a thematic review of published and ‘grey’ literatures, and interviews with key stakeholders involved in supplementary prescribing were undertaken; stage 2 comprised an analysis of community and primary care nurse and pharmacist prescribing using PACTdata (2004 – 2007) and a postal questionnaire survey of nurse (n=518) and pharmacist (n=411) supplementary prescribers; in stage 3, ten detailed case studies of supplementary prescribing practice in various settings were conducted, utilising observations, interviews and prescribing data. Researchwas undertaken from 2006 to 2008.

M3 - Commissioned report

BT - An Evaluation of Supplementary Prescribing in Nursing and Pharmacy

ER -